Skip to main content
Equibles

HYFT · MindWalk Holdings Corp. · Webcasts, Transcripts & Audio

Track HYFT — free

Use HYFT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HYFT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.16 +0.01 (+0.87%) At close · Oct 27 Q1 2027 earnings call transcript
Rebalance outlook locked
Market Cap
$54.18M
Shares
47.11M
Volume · Oct 27 78.64K Avg daily vol (3M) 213.71K

MindWalk Holdings Corp. Webcasts

Earnings calls, investor updates, investor days and conferences for MindWalk Holdings Corp. (HYFT), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Earnings call
FY27 · Q1
2026-09-14
MindWalk Holdings Corp. (HYFT) Q1 2027 Earnings Call Transcript
Positive tone ReefIQ platform and enterprise adoption Wet lab discovery franchise Losses and operating expense investment
Revenue
3.83M CAD
▲ 21.3% YoY
Gross margin
58.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q4
2026-07-22
MindWalk Holdings Corp. (HYFT) Q4 2026 Earnings Call Transcript
Confident tone First recurring platform agreements (ReefIQ/Lens.ai SaaS) Proprietary data and bio-native AI moat Operating expense growth and capital allocation
Revenue
4.12M CAD*
▲ 49.9% YoY
Gross margin
60.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY26 · Q3
2026-03-12
MindWalk Holdings Corp. (HYFT) Q3 2026 Earnings Call Transcript
Confident tone Revenue growth and U.S. commercial focus Dengue vaccine program Lens AI platform / recurring SaaS model
Revenue
4.16M CAD
▲ 52.4% YoY
Gross margin
59.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2025-10-31
Date not confirmed
MindWalk Holdings Corp. (HYFT) Q2 2026 Earnings Call Transcript
Confident tone BioNative AI strategy and HYFT platform SaaS model and sales team build-out Corporate restructuring and divestiture
Revenue
4.12M CAD
▲ 53.9% YoY
Gross margin
64.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2025-07-29
MindWalk Holdings Corp. (HYFT) Q1 2026 Earnings Call Transcript
Confident tone Rebranding to MindWalk Q1 Financial Performance Netherlands Divestiture
Revenue
3.16M CAD
▲ 27.8% YoY
Gross margin
48.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q3
2025-01-31
Date not confirmed
MindWalk Holdings Corp. (HYFT) Q3 2025 Earnings Call Transcript
Confident tone BioStrand / AI platform growth Financial guidance Capital structure and financing
Revenue
2.73M CAD
▼ 56.1% YoY
Diluted EPS
-0.66
Gross margin
64.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2024-12-10
MindWalk Holdings Corp. (HYFT) Q2 2025 Earnings Call Transcript
Confident tone AI-driven antibody discovery / LENSai platform Divestiture of European wet labs Headquarters relocation to Austin, Texas
Revenue
2.68M CAD
▼ 56.4% YoY
Diluted EPS
-0.09
Gross margin
51.1%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2024-07-29
MindWalk Holdings Corp. (HYFT) Q1 2025 Earnings Call Transcript
Positive tone BioStrand LENSai / HYFT AI platform Strategic licensing / Talem pipeline Utrecht protein production / inventory build
Revenue
2.47M CAD
▼ 56.5% YoY
Diluted EPS
-0.15
Gross margin
40.8%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–8 of 8 webcasts
Key facts CIK 1715925 CUSIP 602687105 13F (30d) 3 filings 3 filers Visit website Investor relations